TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15779882

Group type: EXPERIMENTAL
Intervention: Labels for two moving images
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Labels for two still images
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Three repetitions of each label
Number of subjects: 64
Study: 12691269

Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse (Listerine Antiseptic)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Dental floss (Reach Dental Floss)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Negative control rinse
Number of subjects: 319
Study: 10529044

Group type: EXPERIMENTAL
Intervention: Turbohaler
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Easi-breathe
Number of subjects: 102

Group type: COMPARATOR
Intervention: metered-dose inhaler and Volumatic
Number of subjects: 102
Study: 7793216

Group type: EXPERIMENTAL
Intervention: 7.5% sevoflurane in oxygen (n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane with nitrous oxide (n = 19)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (sevoflurane in oxygen and sevoflurane with nitrous oxide)
Number of subjects: 40
Study: 1953259

Group type: EXPERIMENTAL
Intervention: Percutaneous estradiol (E2) 17 beta and natural progesterone for 6 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 32
Study: 475988

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine + cimetidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Chlorpheniramine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 10
Study: 30772205

Group type: EXPERIMENTAL
Intervention: Curriculum intervention
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Wellness intervention
Number of subjects: 1159

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Theory-based determinants
Number of subjects: 1159
Study: 27893484

Group type: EXPERIMENTAL
Intervention: Pelvic and core strengthening program (3 times a week for 6 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normal training without additional pelvic and core strengthening (Control)
Number of subjects: 35
Study: 25347936

Group type: EXPERIMENTAL
Intervention: Hyaluronidase group (ropivacaine 0.5% with 100 IU/ml of hyaluronidase)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (ropivacaine alone)
Number of subjects: 48
Study: 23777849

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation (0.48‐1000 μmol/L, 4 inhalations per dose)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy volunteers and asthmatic patients combined
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation
Number of subjects: 58
Study: 17533024

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 29
Study: 15297192

Group type: EXPERIMENTAL
Intervention: Cisplatin and irinotecan (25 mg/m² and 65 mg/m² weekly for three consecutive weeks, repeated every 28 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cisplatin and irinotecan
Number of subjects: 34
Study: 10795957

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 9341685

Group type: EXPERIMENTAL
Intervention: Stroke Unit
Number of subjects: 220

Group type: COMPARATOR
Intervention: General Wards
Number of subjects: 220
Study: 8519370

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 12
Study: 3535022

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) administered twice daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) administered four times daily
Number of subjects: 40
Study: 31865665

Group type: EXPERIMENTAL
Intervention: Mobilization and SACS injection
Number of subjects: 84

Group type: COMPARATOR
Intervention: SACS injection only
Number of subjects: 84
Study: 31411337

Group type: EXPERIMENTAL
Intervention: Dialogue-based intervention (up to 8 individual sessions aimed at supporting coping and life skills)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 322
Study: 30647740

Group type: EXPERIMENTAL
Intervention: Red light rhinophototherapy (RLRPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 0
Study: 27685347

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nerve stimulator guidance
Number of subjects: 12
Study: 24221533

Group type: EXPERIMENTAL
Intervention: Alcohol-dependent subjects
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 36
Study: 22661489

Group type: EXPERIMENTAL
Intervention: lamivudine‐zidovudine plus efavirenz
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: atazanavir, emtricitabine, and didanosine‐EC
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: emtricitabine‐tenofovir‐disoproxil fumarate plus efavirenz
Number of subjects: 860

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 860
Study: 19597646

Group type: EXPERIMENTAL
Intervention: Cefepime (CFP) monotherapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Ceftriaxone plus amikacin (CFT+AK)
Number of subjects: 57
Study: 17065275

Group type: EXPERIMENTAL
Intervention: Topical cord applications of mustard oil
Number of subjects: 17198

Group type: EXPERIMENTAL
Intervention: Topical applications of other potentially unclean substances
Number of subjects: 17198

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact
Number of subjects: 17198

Group type: EXPERIMENTAL
Intervention: Hand washing by birth attendants
Number of subjects: 17198

Group type: EXPERIMENTAL
Intervention: Hand washing by caretakers
Number of subjects: 17198
Study: 15216462

Group type: EXPERIMENTAL
Intervention: nelfinavir plus stavudine and lamivudine
Number of subjects: 653

Group type: COMPARATOR
Intervention: lopinavir/ritonavir plus stavudine and lamivudine
Number of subjects: 653
Study: 12512233

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/daily per oral)
Number of subjects: 40
Study: 9586148

Group type: EXPERIMENTAL
Intervention: Acute Bed Rest (ABR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rigorous Bed Rest (RBR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ambulatory Control Subjects (ACS)
Number of subjects: 30
Study: 8580292

Group type: EXPERIMENTAL
Intervention: Interactive multimedia learning system
Number of subjects: 0
Study: 2696483

Group type: EXPERIMENTAL
Intervention: Inadine (rayon dressing with 10 per cent povidone iodine ointment)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Inadine
Number of subjects: 213

Group type: COMPARATOR
Intervention: Bactigras (tulle gras dressing with 0.5 per cent Chlorhexidine Acetate B.P.)
Number of subjects: 213
Study: 772831

Group type: EXPERIMENTAL
Intervention: Oxprenolol (Trasicor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study: 31990089

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Promestriene
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Vaginal lubricant
Number of subjects: 72
Study: 30543801

Group type: EXPERIMENTAL
Intervention: Forced exercise + RTP (FE+RTP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Voluntary exercise + RTP (VE+RTP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stroke education + RTP (EDU+RTP)
Number of subjects: 40
Study: 27930813

Group type: EXPERIMENTAL
Intervention: Free gingival grafts (FGGs)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Oral prophylaxis only
Number of subjects: 28
Study: 25759551

Group type: EXPERIMENTAL
Intervention: Magnifying narrow band imaging
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lugol chromoendoscopy
Number of subjects: 51
Study: 23275313

Group type: EXPERIMENTAL
Intervention: Telemonitoring device (Bluetooth-enabled BP cuff with Internet-enabled hub)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 43
Study: 20419562

Group type: EXPERIMENTAL
Intervention: Written self-disclosure (WSD) in addition to standard medical care (SMC)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard medical care (SMC) alone
Number of subjects: 63
Study: 19380660

Group type: EXPERIMENTAL
Intervention: Acitretin (25 mg) plus Pioglitazone hydrochloride (15 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Acitretin (25 mg) plus placebo
Number of subjects: 41
Study: 17476675

Group type: EXPERIMENTAL
Intervention: Clinical response or remission (defined using the Mayo score)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Patients in clinical remission at week 30
Number of subjects: 728

Group type: COMPARATOR
Intervention: Patients not in clinical remission at week 30
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Patients in clinical remission
Number of subjects: 728
Study: 15185883

Group type: EXPERIMENTAL
Intervention: Tissue Doppler (TD) assessment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Standard echocardiography
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Overall population analysis
Number of subjects: 28
Study: 11352437

Group type: EXPERIMENTAL
Intervention: Single 200mg oral dose of moxifloxacin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 9044494

Group type: EXPERIMENTAL
Intervention: Automated External Defibrillator (AED)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Blind Manual Defibrillation (BMD)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: AED
Number of subjects: 50
Study: 7704289

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 3296721

Group type: EXPERIMENTAL
Intervention: Diet treatment and one of five active drug regimens (enalapril, doxazosin, acebutolol, amlodipine, chlorthalidone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet treatment alone
Number of subjects: 0
Study: 29335748

Group type: EXPERIMENTAL
Intervention: Hydrogel implant (Cartiva™)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Autologous osteochondral transplantation (AOT)
Number of subjects: 38
Study: 27096383

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 56
Study: 25004265

Group type: EXPERIMENTAL
Intervention: Norepinephrine (NE) infusion (0.15 mcg/kg/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline infusion (placebo)
Number of subjects: 40
Study: 22155106

Group type: EXPERIMENTAL
Intervention: Prebiotic infant formula supplemented with Lactobacillus fermentum CECT5716
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (same formula without probiotic)
Number of subjects: 0
Study: 20444777

Group type: EXPERIMENTAL
Intervention: Educational intervention (video, lecture with handout, discussion)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (handout only)
Number of subjects: 121
Study: 18185903

Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 322

Group type: COMPARATOR
Intervention: No Burch (control)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Pessary reduction method
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Manual reduction method
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Forceps reduction method
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Swab reduction method
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Speculum reduction method
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: First method of prolapse reduction
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Second method of prolapse reduction
Number of subjects: 322
Study: 16181384

Group type: EXPERIMENTAL
Intervention: Histological alterations in GERD patients
Number of subjects: 135

Group type: COMPARATOR
Intervention: Histological alterations in control group
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Histology in patients with erosive esophagitis
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Histology in patients with nonerosive reflux disease (NERD)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Cut-off value for microscopic lesions
Number of subjects: 135
Study: 12527953

Group type: EXPERIMENTAL
Intervention: Sucralfate mouthwash
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 81
Study: 10688504

Group type: EXPERIMENTAL
Intervention: Misgav Ladach caesarean section technique
Number of subjects: 339

Group type: COMPARATOR
Intervention: Conventional lower midline incision procedure
Number of subjects: 339
Study: 8822677

Group type: EXPERIMENTAL
Intervention: Immediate physiotherapy (n = 9)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (waited 2 months, n = 8)
Number of subjects: 22
Study: 1461625

Group type: EXPERIMENTAL
Intervention: Megestrol acetate at a dose of 480 mg/day for 3-4 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Megestrol acetate at a dose of 160 mg/day for 3-4 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (combined data for both doses)
Number of subjects: 66
Study: 6428619

Group type: EXPERIMENTAL
Intervention: Insulin (up to 48 units of highly purified porcine lente insulin)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 58
Study: 31697453

Group type: EXPERIMENTAL
Intervention: Oral health program including individual oral hygiene monitoring for 2 months, awareness sessions, practical demonstration of toothbrushing and adaptive techniques with role-play.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group received awareness sessions and practical demonstrations without individual monitoring.
Number of subjects: 62
Study: 31590104

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 49
Study: 28190468

Group type: EXPERIMENTAL
Intervention: 1% w/w CA-oil lotion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5% w/w CA-oil lotion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (base-lotion)
Number of subjects: 60
Study: 27259317

Group type: EXPERIMENTAL
Intervention: Intensity‐modulated radiation therapy (IMRT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional radiation therapy (CRT)
Number of subjects: 130
Study: 23880258

Group type: EXPERIMENTAL
Intervention: 1% NaOCl (G1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) gel (G2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1% NaOCl + Ca(OH)2 (G3)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2% CHX gel + Ca(OH)2 (G4)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2-visit treatment (G3 and G4)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1-visit treatment (G1 and G2)
Number of subjects: 48
Study: 21972642

Group type: EXPERIMENTAL
Intervention: Acupuncture knife therapy
Number of subjects: 304

Group type: COMPARATOR
Intervention: Blocking therapy
Number of subjects: 304
Study: 19778736

Group type: EXPERIMENTAL
Intervention: Hero 642
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: K3
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ProTaper Universal
Number of subjects: 67
Study: 16915770

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) analysis in CAD patients without MI
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) analysis in CAD patients with MI
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) analysis in CAD patients with MI and VT
Number of subjects: 144

Group type: COMPARATOR
Intervention: Magnetocardiography (MCG) analysis in healthy subjects
Number of subjects: 144
Study: 12207627

Group type: EXPERIMENTAL
Intervention: 1.25 mg tibolone
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 2.5 mg tibolone
Number of subjects: 2

Group type: COMPARATOR
Intervention: 1.25 mg and 2.5 mg tibolone
Number of subjects: 2
Study: 10509987

Group type: EXPERIMENTAL
Intervention: Preoperative IABP therapy starting 2 hours (T2), 12 hours (T12), or 24 hours (T24) before the operation.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preoperative IABP therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no preoperative IABP)
Number of subjects: 60
Study: 8551321

Group type: EXPERIMENTAL
Intervention: Intrathecal synthesis of IgG (quantitative measurement, log IgG index)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Qualitative measurement (isoelectric focusing)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Quantitative tests for intrathecal synthesis of IgG
Number of subjects: 20
Study: 2031517

Group type: EXPERIMENTAL
Intervention: Ofloxacin (300 mg, taken twice daily for 7 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 40
Study: 7198936

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy of vincristine, bleomycin, methotrexate, hydrocortisone, and 5-fluorouracil given over 24 hours every 2 to 3 weeks.
Number of subjects: 155

Group type: COMPARATOR
Intervention: Chemotherapy before radiation therapy or surgery.
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Primary adjuvant chemotherapy without cis-platinum.
Number of subjects: 155
Study: 24049896

Group type: EXPERIMENTAL
Intervention: Direct fluorescent antibody test
Number of subjects: 0
Study: 29951769

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 26606886

Group type: EXPERIMENTAL
Intervention: Choice from similar products (apple purees)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Choice from dissimilar products (desserts)
Number of subjects: 160

Group type: COMPARATOR
Intervention: No choice session (one product served randomly)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Choice from pleasant products
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Choice from unpleasant products
Number of subjects: 160
Study: 24961816

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: pantoprazole
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: metoclopramide
Number of subjects: 85

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 85
Study: 22492244

Group type: EXPERIMENTAL
Intervention: HPV-16/18 virus-like particle vaccine
Number of subjects: 4808

Group type: COMPARATOR
Intervention: HAV vaccine
Number of subjects: 4808
Study: 20012448

Group type: EXPERIMENTAL
Intervention: Low-load resistance training (LLRT) with blood flow restriction (BFR) at 25% 1 RM
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low-load resistance training (LLRT) with blood flow restriction (BFR) at 50% 1 RM
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-load resistance training (LLRT) with unrestricted blood flow
Number of subjects: 16
Study: 18519324

Group type: EXPERIMENTAL
Intervention: Early motion group (mobilization within two weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late motion group (mobilization at six weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Early motion group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late motion group
Number of subjects: 60
Study: 15793272

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral treatment (CBT) combined with asthma education (AE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 48
Study: 12590626

Group type: EXPERIMENTAL
Intervention: Psychogeriatric case management
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: General practitioners with specialist psychogeriatric consultation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 86
Study: 10594293

Group type: EXPERIMENTAL
Intervention: Topical Skin Protectant (TSP)
Number of subjects: 50
Study: 8912130

Group type: COMPARATOR
Intervention: Intravenous ticarcillin and clavulinic acid (Timentin) pre-ERCP (group I)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Intravenous ticarcillin and clavulinic acid (Timentin) plus 3 days of oral amoxycillin and clavulinic acid (Augmentin) (group II)
Number of subjects: 156
Study: 1811329

Group type: EXPERIMENTAL
Intervention: Nizoral cream containing ketoconazole
Number of subjects: 56
Study: 7039814

Group type: EXPERIMENTAL
Intervention: FU + ME
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: FU + ME + VC
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: FU + ME + DC
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: FU + ME + VC + DC
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: FU I.V. + HU P.O.
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Overall (all treatments)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Treatment C and D (DC containing)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Treatment D
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Treatment A (FU + ME)
Number of subjects: 472
Study: 31189978

Group type: EXPERIMENTAL
Intervention: Anagliptin
Number of subjects: 353

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 353
Study: 30307270

Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innovative study designs and methods
Number of subjects: 0
Study: 26467358

Group type: EXPERIMENTAL
Intervention: Metoprolol (1 x 50 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Carvedilol (2 x 12.5 mg)
Number of subjects: 100
Study: 24838434

Group type: EXPERIMENTAL
Intervention: Intervention arm of a randomized controlled study
Number of subjects: 1342
Study: 22205496

Group type: EXPERIMENTAL
Intervention: Budiodarone 400 mg BID
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Budiodarone 600 mg BID
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 20976388

Group type: EXPERIMENTAL
Intervention: GaAlAs laser λ 830 nm, 40 mW, 5J/cm²
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo application (0 J/cm²)
Number of subjects: 40
Study: 17239324

Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of a 5-HT3 antagonist, steroids, and aprepitant
Number of subjects: 0